As a physician-scientist and oncology leader with deep experience in precision medicine, diagnostics, and patient-centered innovation, Dr. Reddy has been dedicated to advancing cancer care through the integration of cutting-edge science and compassionate clinical practice. He has led multidisciplinary teams in both academic and industry settings, driving the development and implementation of transformative diagnostics that improve early cancer detection and treatment outcomes. His mission aligns closely with Mercy BioAnalytics’ vision to reduce suffering and save lives through accessible, life-saving technology. Together, they share a commitment to scientific rigor, clinical excellence, and improving health equity by making early detection available to all who need it, not just the fortunate few.
From January of 2021 to July of 2023, Dr. Reddy served as Senior Vice President and Enterprise Oncology Head of Labcorp’s enterprise oncology unit, which utilizes the combined assets of Labcorp’s drug development and diagnostics businesses to help bring the right treatment to the right patient at the right time.
Dr. Reddy previously served as Vice President of Medical Affairs at Foundation Medicine, Inc. He is triple board-certified in internal medicine, medical oncology, and hematology. He previously practiced medicine and served in leadership positions for more than 10 years in various clinical settings, including academia, private practice, and managed care.